A Study to Investigate Treatment Patterns and Effectiveness of Tislelizumab in European Patients With Resectable or Advanced Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)
Clinical trial NCT07652736 · RECRUITING
Trial details
- NCT number
- NCT07652736
- Sponsor
- BeOne Medicines
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-06-05
- Primary completion
- 2027-11-15
- Enrollment
- 440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.